Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)
NCT05506618
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST:
Nasal Swab
DIAGNOSTIC_TEST:
Nasopharyngeal swab
Sponsor
LumiraDx UK Limited